| Print
Moderna (MRNA)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Address
200 Technology Square
Cambridge
MA
USA
02139
Telephone
+1 617 7146500
Forecast key dates
| Name | Key Date |
|---|---|
| Moderna Inc Second Quarter Earnings Conference Call for 2027 | 2027-07-30T08:00:00 |
| Moderna Inc Second Quarter Earnings Results for 2027 | 2027-07-30T00:00:00 |
| Moderna Inc Annual General Meeting for 2027 | 2027-05-06T08:00:00 |
| Moderna Inc First Quarter Earnings Conference Call for 2027 | 2027-04-30T08:00:00 |
| Moderna Inc First Quarter Earnings Results for 2027 | 2027-04-30T00:00:00 |
| Moderna Inc Annual Report for 2026 | 2027-02-19T00:00:00 |
| Moderna Inc Fourth Quarter Earnings Conference Call for 2026 | 2027-02-12T08:00:00 |
| Moderna Inc Fourth Quarter Earnings Results for 2026 | 2027-02-12T00:00:00 |
| Moderna Inc Third Quarter Earnings Conference Call for 2026 | 2026-11-06T08:00:00 |
| Moderna Inc Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |